References
- Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
- Jeha S, Pui CH. Risk adapted treatment of pediatric acute lymphoblastic leukemia. Hematol Oncol Clinic Am 2009;23:973–990.
- Jamil A, Theil KS, Ruymann FB, et al. TEL/AML-1 gene. Its frequency and prognostic significance in childhood. Leukemia. Cancer Genet Cytogenet2000;122:73–78.
- Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors:a Children's Oncology Group study. Blood 2008;111:5477–5485.
- Juarez-Velazquez R, Reyes-Leon A, Salas-Labadia C, et al. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia. Leuk Lymphoma 2014;55:2305–2311.
- Flotho C, Coustan-Smith E, Pei D, et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood 2006;108:1050–1057.
- Flotho C, Couston-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007;110:1271–1277.
- Jiao Y, Cui L, Gao C, et al. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia. Leuk Res 2012; 13:67–71.
- Mullinghan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470–480.
- Perez-Andreu V, Roberts KG, Harvey RC, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 2013;45:1494–1498.